Pharmamarketeer

Early-stage osteoarthritis drug wins prestigious innovation award

UK-based biotech company rewarded for unique approach to drug development by UK Government’s innovation bodyAKL Research and Development (AKLRD) today announces its investigational medicine for osteoarthritis (OA) has been awarded a prestigious grant from Innovate UK, the leading government innovation agency.

Medhc-fases-banner
Advertentie(s)